Testing effectiveness (Phase 2)Active Not RecruitingNCT05210868
What this trial is testing
A Phase I/II Study of CM355 in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma (B-NHL)
Who this might be right for
Hematoma
Beijing InnoCare Pharma Tech Co., Ltd. 184